Congratulations to Irati Beltrán Hernández and Sebas Pronk (postdocs of the Oliveira Lab)! Lumox won the first prize at the Philips Innovation Award: the largest entrepreneurship award in the Netherlands organized by students!
About the start-up:
Lumox is developing a light-activated cancer therapy that selectively targets only cancer cells — reducing the need for invasive surgery. Especially promising for head and neck cancers, their approach minimizes harm to healthy tissue and could expand to other solid tumors.
In this short video, filmed in Rotterdam, Sebas and Irati introduce their light-activated cancer therapy — designed to kill tumors with precision while sparing healthy tissue.